JNF said...
I just saw that the company, SPL Medical, that owns the agent has renamed it Ferrotran and is conducting trials in Europe at Radboud University. Sounds like what you are reporting, Djin.
Yes, that's where that study's investigators are based.
Djin
Post Edited (DjinTonic) : 5/18/2021 12:52:57 PM (GMT-6)